SCHEMBL235016

SCHEMBL235016

CCCCCCOc1cc(C=Cc2cc(OCCCCCC)c(C=Cc3cc(OCCCCCC)c(C=O)cc3OCCCCCC)cc2OCCCCCC)c(OCCCCCC)cc1C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
ALDH1A1 P00352 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 1/20 0.40
NR1I2 O75469 1/20 0.40
CHRM2 P08172 1/20 0.40
CYP3A4 P08684 1/20 0.40
ADRA2A P08913 1/20 0.40
MAPT P10636 1/20 0.40
OPRK1 P41145 1/20 0.40
HTR2B P41595 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
PSEN1 P49768 2/20 0.39
PSEN2 P49810 2/20 0.39
APH1B Q8WW43 2/20 0.39
NCSTN Q92542 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3628620 0.95 LMNA (0.44) LMNAALDH1A1TDP1KDM4ETSHR
SCHEMBL26103495 0.95 LMNA (0.44) LMNAALDH1A1TDP1KDM4ETSHR
SCHEMBL18901651 0.95 LMNA (0.44) LMNAALDH1A1TDP1KDM4ETSHR
SCHEMBL31078471 0.95 LMNA (0.44) LMNAALDH1A1TDP1KDM4ETSHR
SCHEMBL278733 0.95 LMNA (0.44) LMNAALDH1A1TDP1KDM4ETSHR
SCHEMBL7717723 0.94 ALDH1A1 (0.51) LMNAALDH1A1TDP1KDM4ETSHR
SCHEMBL28421317 0.93 LMNA (0.46) LMNAALDH1A1TDP1KDM4ETSHR
SCHEMBL3499122 0.92 AHR (0.42) LMNAMEN1NR1I2CHRM2CYP3A4
SCHEMBL6883769 0.87 AHR (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL11317160 0.87 LMNA (0.47) LMNAALDH1A1TDP1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8754039-B2 Targeted antimicrobial moieties C3 JIAN, INC. (US) 2014-06-17 US claimed
EP-3565573-B1 PAC1 RECEPTOR AGONISTS (MAXCAPS) AND USES THEREOF UNIV CALIFORNIA (US) 2023-08-23 EP disclosed
US-20230052825-A1 ANTIMICROBIAL AND ANTICANCER PEPTIDES & CONJUGATES AND COMPOSITIONS, METHODS, ARTICLES & KITS RELATING THERETO George Mason Research Foundation, Inc. (US) 2023-02-16 US disclosed
US-11447533-B2 Antimicrobial and anticancer peptides and conjugates and compositions, methods, articles and kits relating thereto George Mason Research Foundation, Inc. (US) 2022-09-20 US disclosed
US-11219697-B2 Osteoadsorptive fluorogenic substrate of cathepsin k for imaging osteoclast activity and migration THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-01-11 US disclosed
US-10954271-B2 Anti-microbial peptides TENSIVE CONTROLS, INC. (US) 2021-03-23 US disclosed
US-20200215205-A1 AN OSTEOADSORPTIVE FLUOROGENIC SUBSTRATE OF CATHEPSIN K FOR IMAGING OSTEOCLAST ACTIVITY AND MIGRATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-07-09 US disclosed
US-20200190156-A1 ANTIMICROBIAL AND ANTICANCER PEPTIDES & CONJUGATES AND COMPOSITIONS, METHODS, ARTICLES & KITS RELATING THERETO George Mason Research Foundation, Inc. (US) 2020-06-18 US disclosed
EP-3194422-B1 ANTI-MICROBIAL PEPTIDES TENSIVE CONTROLS INC (US) 2020-04-29 EP disclosed
US-20200109171-A1 ANTI-MICROBIAL PEPTIDES ENDEVICA BIO, INC. 2020-04-09 US disclosed
US-8889156-B2 Calcium-binding agents induce hair growth and/or nail growth THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-11-18 US disclosed
US-8754039-B2 Targeted antimicrobial moieties C3 JIAN, INC. (US) 2014-06-17 US disclosed
WO-2012006187-A2 METHODS AND DEVICES FOR THE SELECTIVE DETECTION OF MICROORGANISMS C3 JIAN, INC. (US) 2012-01-12 WO disclosed
US-20120003661-A1 METHODS AND DEVICES FOR THE SELECTIVE DETECTION OF MICROORGANISMS C3 JIAN, INC. (US) 2012-01-05 US disclosed
US-20110039762-A1 TARGETED ANTIMICROBIAL MOIETIES C3 JIAN, INC. (US) 2011-02-17 US disclosed
US-20110039761-A1 TARGETED ANTIMICROBIAL MOIETIES C3 JIAN, INC. (US) 2011-02-17 US disclosed
US-20110039763-A1 TARGETED ANTIMICROBIAL MOIETIES C3 JIAN, INC. (US) 2011-02-17 US disclosed
US-20100316643-A1 TARGETED ANTIMICROBIAL MOIETIES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-12-16 US disclosed
US-20100239503-A1 CALCIUM-BINDING AGENTS INDUCE HAIR GROWTH AND/OR NAIL GROWTH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-09-23 US disclosed
US-20100184683-A1 ANTIBACTERIAL AND ANTIFUNGAL PEPTIDES C3 JIAN, INC. (US) 2010-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11219697-B2 Osteoadsorptive fluorogenic substrate of cathepsin k for imaging osteoclast activity and migration CTSS, CTSK, CTSF LMNA 2373/4885ALDH1A1 3777/4885TDP1 2004/4885
US-20100239503-A1 CALCIUM-BINDING AGENTS INDUCE HAIR GROWTH AND/OR NAIL GROWTH S100B, S100A6, CALCB LMNA 4426/4885ALDH1A1 3946/4885TDP1 3905/4885
US-20200215205-A1 AN OSTEOADSORPTIVE FLUOROGENIC SUBSTRATE OF CATHEPSIN K FOR IMAGING OSTEOCLAST ACTIVITY AND MIGRATION CTSS, CTSK, CTSF LMNA 2473/4885ALDH1A1 3743/4885TDP1 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.